Davenport & Co’s CME Group CME Stock Holding History

Davenport & Co’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.82M	Sell	30,874 -755	-2%	-$209K	0.03%	304
2026 Q1	$9.34M	Buy	31,629 +6,844	+28%	+$2.03M	0.05%	245
2025 Q4	$6.77M	Buy	24,785 +13,109	+112%	+$3.56M	0.04%	287
2025 Q3	$3.15M	Sell	11,676 -13	-0.1%	-$3.54K	0.02%	435
2025 Q2	$3.22M	Sell	11,689 -933	-7%	-$254K	0.02%	411
2025 Q1	$3.35M	Sell	12,622 -2,086	-14%	-$515K	0.02%	378
2024 Q4	$3.42M	Buy	14,708 +9,696	+193%	+$2.23M	0.02%	359
2024 Q3	$1.11M	Sell	5,012 -191	-4%	-$39.5K	0.01%	614
2024 Q2	$1.02M	Sell	5,203 -98	-2%	-$20.2K	0.01%	612
2024 Q1	$1.14M	Sell	5,301 -170	-3%	-$35.7K	0.01%	589
2023 Q4	$1.15M	Sell	5,471 -46	-0.8%	-$9.81K	0.01%	544
2023 Q3	$1.1M	Buy	5,517 +19	+0.3%	+$3.78K	0.01%	520
2023 Q2	$1.02M	Buy	5,498 +480	+10%	+$88.7K	0.01%	554
2023 Q1	$961K	Buy	5,018 +1,715	+52%	+$310K	0.01%	548
2022 Q4	$556K	Buy	3,303 +47	+1%	+$8.17K	﹤0.01%	655
2022 Q3	$577K	Buy	3,256 +27	+0.8%	+$5.34K	0.01%	635
2022 Q2	$661K	Sell	3,229 -51	-2%	-$10.8K	0.01%	602
2022 Q1	$780K	Buy	3,280 +101	+3%	+$23.7K	0.01%	612
2021 Q4	$726K	Sell	3,179 -1,031	-24%	-$227K	﹤0.01%	657
2021 Q3	$814K	Buy	4,210 +999	+31%	+$202K	0.01%	592
2021 Q2	$683K	Sell	3,211 -239	-7%	-$50.5K	0.01%	563
2021 Q1	$705K	Buy	3,450 +15	+0.4%	+$2.95K	0.01%	463
2020 Q4	$625K	Sell	3,435 -249,785	-99%	-$42.5M	0.01%	466
2020 Q3	$42.4M	Sell	253,220 -7,441	-3%	-$1.25M	0.47%	83
2020 Q2	$42.4M	Buy	260,661 +764	+0.3%	+$137K	0.52%	74
2020 Q1	$44.9M	Sell	259,897 -2,455	-0.9%	-$489K	0.65%	56
2019 Q4	$52.7M	Buy	262,352 +597	+0.2%	+$122K	0.56%	66
2019 Q3	$51.8M	Sell	261,755 -4,209	-2%	-$879K	0.62%	59
2019 Q2	$51.6M	Sell	265,964 -4,695	-2%	-$866K	0.61%	60
2019 Q1	$44.5M	Sell	270,659 -689	-0.3%	-$122K	0.56%	66
2018 Q4	$51M	Sell	271,348 -7,211	-3%	-$1.33M	0.7%	47
2018 Q3	$47.4M	Sell	278,559 -244	-0.1%	-$41.1K	0.55%	69
2018 Q2	$45.7M	Sell	278,803 -3,710	-1%	-$606K	0.56%	73
2018 Q1	$45.7M	Buy	282,513 +1,130	+0.4%	+$180K	0.56%	73
2017 Q4	$41.1M	Sell	281,383 -1,901	-0.7%	-$271K	0.49%	89
2017 Q3	$38.4M	Sell	283,284 -1,816	-0.6%	-$229K	0.49%	89
2017 Q2	$35.7M	Sell	285,100 -76,426	-21%	-$9.14M	0.47%	90
2017 Q1	$41.9M	Sell	361,526 -22,581	-6%	-$2.72M	0.6%	65
2016 Q4	$44.3M	Sell	384,107 -1,958	-0.5%	-$218K	0.64%	61
2016 Q3	$40.4M	Sell	386,065 -128,672	-25%	-$13.4M	0.59%	66
2016 Q2	$50.1M	Sell	514,737 -4,116	-0.8%	-$389K	0.76%	40
2016 Q1	$49.8M	Sell	518,853 -3,950	-0.8%	-$359K	0.78%	40
2015 Q4	$47.4M	Buy	522,803 +2,858	+0.5%	+$269K	0.77%	43
2015 Q3	$48.2M	Sell	519,945 -1,397	-0.3%	-$133K	0.81%	39
2015 Q2	$48.5M	Sell	521,342 -5,836	-1%	-$544K	0.75%	39
2015 Q1	$49.9M	Sell	527,178 -15,969	-3%	-$1.48M	0.77%	37
2014 Q4	$48.1M	Sell	543,147 -10,644	-2%	-$902K	0.78%	41
2014 Q3	$44.3M	Buy	553,791 +7,600	+1%	+$573K	0.77%	41
2014 Q2	$38.8M	Buy	546,191 +164,638	+43%	+$11.6M	0.66%	56
2014 Q1	$28.2M	Buy	+381,553	New	+$28.8M	0.51%	78

Other funds holding CME

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Davenport & Co's CME Position: Q2 2026 in Review

Davenport & Co reduced its CME Group (CME) stake by 2.4% in Q2 2026, selling an estimated $209K and leaving 30,874 shares worth $6.82M. The position accounts for 0.03% of the portfolio, ranked #304.

Davenport & Co first reported a position in CME in Q1 2014 and has held it in 50 quarters since. The position peaked at $52.7M in Q4 2019. 268 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Davenport & Co held 30,874 shares of CME Group worth $6.82M as of Q2 2026.
Davenport & Co sold 755 CME Group shares in Q2 2026, an estimated $209K.
CME Group made up 0.03% of Davenport & Co's portfolio in Q2 2026, its #304 holding.
Davenport & Co first reported a position in CME Group in Q1 2014 and has held it in 50 quarters since.
Davenport & Co's CME Group position peaked at $52.7M in Q4 2019.
268 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.